BoxX-NoAF Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 960 participants.

Also called NCT06989775

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 960 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06989775
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Canada (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06989775. Randomized; triple masking; primary purpose prevention. Start 2025-10-24 (actual); primary completion 2027-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BoxX-NoAF Clinical Trial
Condition
Post Operative Atrial Fibrillation
Condition
Atrial Fibrillation, Postoperative
Intervention (Device)
Isolator® Synergy™ EnCompass® Ablation System and AtriClip® LAA Exclusion System
Lead sponsor
AtriCure, Inc. (class: industry)

Record details

Record id
cardio:ct-nct06989775
Content hash
f0f20a55034f74783cca4deab65f60b21ee1bc161010a6b552c8c713da8662f6